The Deen's ListTM
Our goal since Oct. 2005: Outperform the S&P through up markets and down.
A service of Deen Capital Management, Inc. (www.deencapital.com)
Vol.7 #310 Thursday, December 17, 2009 9:59AM EST

Please read carefully our disclaimers at the end of this newsletter.

Market Stance: BULLISH (since December 1, 2009)

Contents

Performance
Bought Credit Acceptance Corp. (CACC)
Sold S&P Depositary Receipt (SPY) +0.5%
Open Positions
Subscription Information
Privacy Policy
Disclaimers
Contact Us

Performance

Deen Capital S&P 500
Year-to-date as of December 16, 2009 +23.4% * +25.7%
12 months (Dec 16, 2008 to Dec 16, 2009) +22.6% * +24.5%
24 months (Dec 16, 2007 to Dec 16, 2009) -9.6% * -20.7%
36 months (Dec 16, 2006 to Dec 16, 2009) +15.5% * -17.0%
48 months (Dec 16, 2005 to Dec 16, 2009) +41.7% * -4.9%

* An average of managed accounts, net after all commissions and fees.

Click here for more performance data.

Click here for information on managed accounts.

Bought Credit Acceptance Corp. (CACC)

Initial percent of portfolio (approx.)5.0%
Net buy price in managed accounts*$39.16
Most recent close (Dec 16)$39.05
Net change (based on net buy price)+0.11
Today's volume as of 9:44am ET 9,026 ($353,415)
Average daily volume32,600 ($1.3 million)
This year's earnings-per-share$4.57 (est)
Next year's earnings-per-share$4.94 (est)
P/E using next year's earnings7.9 (est)
Earnings growth rate, next 5 yearsn/a
Corporate HeadquartersSouthfield, MI
Web siten/a

* Buy prices shown are net after commissions and fees.

Today, Thursday, December 17, 2009, I bought CACC, for both client and my personal accounts.

Credit Acceptance Corp. provides auto loans to consumers primarily in the United States. They offer their products through a network of automobile dealers.

This stock is a component of the IBD 100 Index. ("IBD" = "Investor's Business Daily")

Here's why I bought this stock:

+ Breakout: Yesterday, the stock was up 8% to $39.05 on very heavy volume. This move was a breakout from an 8-week trading range to a new 10-year high.

+ Volume spike: Yesterday's volume was more than 5 times average, and set a 12-month record.

+ Excellent recent sales growth. Here are the quarterly year-to-year sales growth rates from the last four quarters, in chronological order: +36%, +24%, +23%, and, most recently, for the quarter ended Sep 30, +25% to $100.3 million.

+ Excellent recent earnings-per-share growth. Here are the quarterly EPS figures for the last eight quarters:

Dec 08 vs Dec 07: $0.76 vs $0.48
Mar 09 vs Mar 08: $0.79 vs $0.54
Jun 09 vs Jun 08: $0.96 vs $0.65
Sep 09 vs Sep 08: $1.10 vs $0.72

+ Strong earnings-per-share estimates: According to recent data from First Call, the consensus earnings estimate for 2009 is $4.57, up from 2008 actual earnings of $2.66 and the consensus estimate for 2010 is $4.94. These numbers represent new coverage by a single analyst. 90-days-ago estimates are not available.

+ Valuation: At 8 times next year's estimated earnings, the stock is still, even after yesterday's big gain, attractively priced.

+ The stock's 200-day moving average is rising, indicating a long-term uptrend.

I chose to buy the stock in spite of the following negative factor:

- The company's industry group ("Finance - Consumer / Commercial Loans") is ranked #36 for relative strength out of 197 industry groups tracked by Investor's Business Daily. This ranking changes daily, and it has been generally falling over recent weeks and months.

-KD, Thursday, December 17, 2009

Sold S&P Depositary Receipt (SPY) +0.5%

Net sell price in managed accounts*$110.54
Date(s) boughtNov 13 2009; Nov 16 2009
Net buy price in managed accounts*$110.43
Holding period4.9 weeks
Gain/loss in managed accounts*+0.5% (after commissions)

* Buy and sell prices shown are net after commissions and fees. This means that the gain/loss shown is also net after transaction expenses.

Today, Thursday, December 17, 2009, I sold SPY, first for client accounts, then for my personal accounts.

I sold just enough SPY to pay for CACC. We remain fully invested.

-KD, Thursday, December 17, 2009

Open Positions

Model Portfolio

Company Name Stock
Symbol
Buy
Date
NetBuy
Price*
Current
Price**
Weeks
Held
% of
Portfolio
Gain
(Loss)
Credit Acceptance Corp. CACC 12/17/09 $39.16 $39.05 0.0 5.0% -0.3%
Hi-Tech Pharmacal Co. Inc. HITK 12/09/09 $24.01 $23.47 1.1 4.8% -2.3%
China Education Alliance CEU 12/08/09 $6.40 $5.95 1.3 3.7% -7.0%
AsiaInfo Holdings Inc. ASIA 12/08/09 $29.79 $30.27 1.3 5.1% +1.6%
China Sky One Medical CSKI 12/03/09 $17.40 $18.59 2.0 5.4% +6.9%
Cyberonics Inc. CYBX 12/02/09 $18.06 $20.52 2.1 5.1% +13.6%
Lihua International, Inc. LIWA 12/02/09 $9.99 $10.52 2.1 5.2% +5.3%
China Green Agriculture Inc. CGA 12/01/09 $17.21 $16.49 2.3 4.7% -4.2%
SmartHeat Inc. HEAT 11/30/09 $13.03 $16.08 2.4 5.9% +23.4%
Telestone Technology TSTC 11/25/09 $13.63 $17.25 3.1 6.1% +26.6%
S&P Depositary Receipt SPY 11/25/09 $111.39 $110.60 3.1 24.7% -0.7%
S&P Depositary Receipt SPY 11/16/09 $110.45 $110.60 4.4 19.2% +0.1%
Priceline.com Inc. PCLN 11/10/09 $203.56 $219.63 5.3 5.1% +7.9%
Cash 0.1%  
Total 100%  

* Buy prices shown are net after commissions and fees.

** Current prices are at least 20 minutes old.

Subscription Information

Welcome to The Deen's ListTM, an e-mail stock newsletter from Deen Capital Management, Inc.

My intention is to inform you as quickly as is practical regarding my stock market moves. When I buy or sell a stock, first I take care of client accounts, then I buy/sell for my personal account(s), and then, third, I send out this newsletter.

Your feedback is welcome. Send e-mail to deenslist@deencapital.com. To subscribe or unsubscribe, include the word "subscribe" or "unsubscribe" in the Subject line.

This newsletter is free to managed account clients. For a limited time, it is also free to all interested parties.

Privacy Policy

Your personal information, including your e-mail address, will be held in strict confidence by Deen Capital Management, Inc. We will not share it with or sell it to others.

Disclaimers

All stocks discussed in The Deen's ListTM involve a high degree of risk. It should not be assumed that any stock discussed in The Deen's ListTM or purchased by Deen Capital Management, Inc. will be profitable.

Past performance is not necessarily indicative of future results.

The information contained herein has been compiled from sources deemed to be reliable; however, we are not responsible for its accuracy or completeness.

Contact Us

The Deen's List
PO Box 30925
Santa Barbara, CA 93130
(800) 353-4990
deenslist@deencapital.com

Copyright © 2009 Deen Capital Management, Inc.